The Clorox Company
CLX · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $14,831,647 | $16,669,118 | $19,655,595 | $17,356,471 |
| - Cash | $167,000 | $202,000 | $367,000 | $183,000 |
| + Debt | $2,880,000 | $2,903,000 | $2,924,000 | $3,103,000 |
| Enterprise Value | $17,544,647 | $19,370,118 | $22,212,595 | $20,276,471 |
| Revenue | $7,104,000 | $7,093,000 | $7,389,000 | $7,107,000 |
| % Growth | 0.2% | -4% | 4% | – |
| Gross Profit | $3,194,000 | $3,025,000 | $2,871,000 | $2,491,000 |
| % Margin | 45% | 42.6% | 38.9% | 35% |
| EBITDA | $1,398,000 | $736,000 | $577,000 | $928,000 |
| % Margin | 19.7% | 10.4% | 7.8% | 13.1% |
| Net Income | $810,000 | $280,000 | $149,000 | $462,000 |
| % Margin | 11.4% | 3.9% | 2% | 6.5% |
| EPS Diluted | 6.52 | 2.25 | 1.2 | 3.73 |
| % Growth | 189.8% | 87.5% | -67.8% | – |
| Operating Cash Flow | $981,000 | $695,000 | $1,158,000 | $786,000 |
| Capital Expenditures | -$220,000 | -$212,000 | -$228,000 | -$251,000 |
| Free Cash Flow | $761,000 | $483,000 | $930,000 | $535,000 |